Mkts

Regeneron Pharmaceuticals, Inc.

NASDAQ: REGN
$904.35+1.45 (+0.16%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
887.04911.64
52-week range
591.52991.73
Today
Open887.22
Previous close904.35
Volume—
Valuation
Market cap93.39B
P/E ratio19.39×
EPS (TTM)45.28
Income & risk
Dividend / yield—
Beta0.12
Avg volume784.3K
Discussion

REGN News

Stories mentioning REGN from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue3,605,4003,884,3003,754,3003,675,6003,028,7003,789,2003,720,7003,547,100
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development1,543,5001,626,1001,475,0001,421,7001,327,4001,412,1001,271,5001,200,000
Sales General & Admin647,700775,000657,800634,200633,000792,200714,400758,800
Total Operating Expenses
Operating Income (Loss)642,900879,9001,026,8001,079,500591,700990,2001,179,5001,069,600
Interest Income
Interest Expense
Other Expense201,200176,000755,800442,800322,000(21,600)327,300573,300
Pretax Income831,2001,043,7001,763,3001,518,700905,000958,1001,493,0001,628,100
Tax Provision104,000199,100303,300127,10096,30040,400152,400195,800
Net Income (Loss)727,200844,6001,460,0001,391,600808,700917,7001,340,6001,432,300
Earnings Per Share (Basic)6.998.0714.0913.247.588.5112.4013.25
Earnings Per Share (Diluted)6.757.7813.6212.817.277.9711.5412.41
Weighted Average Shares Outstanding (Basic)104,000104,600103,600105,100106,700107,900108,100108,100
Weighted Average Shares Outstanding (Diluted)107,700108,600107,200108,600111,200115,100116,200115,400

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About REGN

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a stock listed on the Nasdaq Stock Market under the ticker symbol REGN. It last traded at $904.35 (Nov 6, 2026, 4:00 PM ET), up 0.2% on the day. That gives Regeneron Pharmaceuticals a market capitalisation of $93.4B and a price-to-earnings ratio of 19.4.

Over the past 52 weeks REGN has traded between $591.52 and $991.73.

Revenue for the quarter ended Mar 31, 2026 was $3.6B; net income $727.2M. Revenue was up 19.0% from $3.0B in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$3.6B$727.2M20.2%
Dec 31, 2025$3.9B$844.6M21.7%
Sep 30, 2025$3.8B$1.5B38.9%
Jun 30, 2025$3.7B$1.4B37.9%

From Regeneron Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…